Iniciar sesión Regístrese gratis

Accelerate Diagnostics Inc Relación de reducción

¿Qué es el Relación de reducción de Accelerate Diagnostics Inc?

El Relación de reducción de Accelerate Diagnostics Inc es 17.84

¿Cuál es la definición de Relación de reducción?



El ratio corto es el número de acciones vendidas en corto dividido por el volumen promedio diario.

Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.

The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.

Relación de reducción de compañías en Sector Health Care en NASDAQ en comparadas con Accelerate Diagnostics Inc

¿Qué hace Accelerate Diagnostics Inc?

accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.

Empresas con relación de reducción similar a Accelerate Diagnostics Inc